Company Overview of NanoCyte, Inc.
NanoCyte, Inc. engages in the development of topical delivery platform technology for the cosmeceutical and pharmaceutical markets. The company provides a topical formulation that penetrates the skin, and delivers the compound into the epidermal skin layer. Its products are used for various cosmeceutical applications, such as acne treatments, whitening, pain relief, anti-aging treatments, and slimming treatments; and pharmaceutical applications, which include topical lidocaine for local anesthesia. The company was founded in 2000 and is based in Or Akiva, Israel.
PO Box 264
Or Akiva, 30652
Founded in 2000
972 4 6750645
972 4 6750646
Key Executives for NanoCyte, Inc.
Similar Private Companies By Industry
|3PLW Ltd.||Middle East/Africa|
|Accelerated Evolution Biotechnologies Ltd||Middle East/Africa|
|Adante Ltd.||Middle East/Africa|
|Advanced Biotechnology Ltd.||Middle East/Africa|
|Advanced Medical Analysis (AMA) Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact NanoCyte, Inc., please visit www.nano-cyte.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.